Merck KGaA Stock

Equities

MRK

DE0006599905

Pharmaceuticals

Market Closed - Xetra 11:35:01 2024-04-26 EDT 5-day change 1st Jan Change
151.8 EUR +1.10% Intraday chart for Merck KGaA +3.94% +5.31%

Financials

Sales 2024 * 21.25B 22.72B 31.06B Sales 2025 * 22.5B 24.06B 32.89B Capitalization 65.98B 70.54B 96.44B
Net income 2024 * 2.97B 3.18B 4.34B Net income 2025 * 3.48B 3.72B 5.08B EV / Sales 2024 * 3.42 x
Net Debt 2024 * 6.79B 7.26B 9.93B Net Debt 2025 * 4.83B 5.17B 7.06B EV / Sales 2025 * 3.15 x
P/E ratio 2024 *
22.2 x
P/E ratio 2025 *
18.9 x
Employees 62,908
Yield 2024 *
1.52%
Yield 2025 *
1.59%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart
1 day+1.10%
1 week+3.94%
Current month-7.24%
1 month-4.62%
3 months-2.66%
6 months+5.05%
Current year+5.31%
More quotes
1 week
146.10
Extreme 146.1
155.60
1 month
142.70
Extreme 142.7
164.85
Current year
140.50
Extreme 140.5
164.85
1 year
134.30
Extreme 134.3
172.40
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
59.38
Extreme 59.375
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 20-07-12
Director of Finance/CFO 56 14-07-31
Director of Finance/CFO 53 19-04-25
Members of the board TitleAgeSince
Director/Board Member 75 14-05-08
Director/Board Member - -
Chairman 67 19-04-25
More insiders
Date Price Change Volume
24-04-26 151.8 +1.10% 282,863
24-04-25 150.1 -1.48% 259,860
24-04-24 152.4 -0.85% 339,364
24-04-23 153.6 +4.03% 503,255
24-04-22 147.7 +1.16% 214,993

Delayed Quote Xetra, April 26, 2024 at 11:35 am

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
151.8 EUR
Average target price
182 EUR
Spread / Average Target
+19.93%
Consensus